SCHEMBL8630171

SCHEMBL8630171

NS(=O)(=O)c1ccccc1-c1nn(Cc2ccccc2)c(C(F)(F)F)c1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.45
PTGS1 P23219 2/20 0.44
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
ALDH1A1 P00352 1/20 0.38
ENPP1 P22413 1/20 0.37
F10 P00742 3/20 0.37
NR1H2 P55055 1/20 0.37
NR1H3 Q13133 1/20 0.37
ESR1 P03372 1/20 0.36
F2 P00734 2/20 0.36
PRSS1 P07477 2/20 0.36
PRSS2 P07478 2/20 0.36
PRSS3 P35030 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TRPV1 Q8NER1 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8635534 0.94 PTGS2 (0.53) PTGS2PTGS1GAAALDH1A1ENPP1
SCHEMBL8629984 0.94 PTGS2 (0.44) PTGS2PTGS1ALDH1A1ENPP1F10
SCHEMBL8629933 0.93 PTGS2 (0.46) PTGS2PTGS1POLBGAAALDH1A1
SCHEMBL8629384 0.90 PTGS2 (0.44) PTGS2PTGS1ENPP1F10ESR1
SCHEMBL8631441 0.90 F10 (0.49) PTGS2PTGS1F10F2
SCHEMBL8632872 0.88 PTGS2 (0.39) PTGS2PTGS1POLBGAAALDH1A1
SCHEMBL8632879 0.88 PTGS2 (0.58) PTGS2PTGS1POLBF10F2
SCHEMBL8630527 0.86 PTGS2 (0.42) PTGS2PTGS1F10F2PRSS1
SCHEMBL8631861 0.86 HTR7 (0.38) PTGS2PTGS1ALDH1A1ENPP1F10
SCHEMBL8628841 0.85 PTGS2 (0.43) PTGS2PTGS1F10F2PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed